Cite
HARVARD Citation
Brümmendorf, T. et al. (2016). Factors influencing long‐term efficacy and tolerability of bosutinib in chronic phase chronic myeloid leukaemia resistant or intolerant to imatinib. British journal of haematology. pp. 97-110. [Online].